Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-15
    E.g., 2018-10-15

Archive Search

1 results
12:00 AM, Nov 02, 2009  |  BC Week In Review | Company News  |  Other News

SciClone cancer news

with cuts primarily in research and development. In October, SciClone discontinued a Phase II of RP101
to treat advanced pancreatic cancer based on the recommendation of an independent DSMC. RP101 is a …